Selskabets formål er udvikling og salg af medical devices samt al virksomhed, som efter bestyrelsens skøn er beslægtet hermed
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 214.3 mio. | 43.4 mio. | 170.7 mio. | 95.2 mio. | 127 | |
CVR: 29411166
Secondary names: MBH-INTERNATIONAL A/S
Previous names: MBH-INTERNATIONAL ApS, MBH-INTERNATIONAL A/S
Compared to 405 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Qufora A/S demonstrates strong financial health with a consistent upward trajectory in revenue and profit over the past few years. Revenue increased from 94.4 million DKK in 2021 to 214.3 million DKK in 2025, while profit rose from 11.2 million DKK to 43.4 million DKK in the same period, indicating robust growth and improving profitability. The company's equity has also strengthened, reaching 95.2 million DKK in 2025, which supports a solid financial foundation. However, the fluctuating profit margins, particularly the dip in 2023, may warrant attention. Overall, Qufora A/S is well-positioned within the wholesale trade of medicinal products and nursing supplies, reflecting a growing demand in the healthcare sector.
AI-generated summary
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB appointed as auditor
inforevision statsautoriseret revisionsaktieselskab resigned as auditor
Michael Molbech Sorth joined the board
Morten Højland Boesen joined as director
Michael Molbech Sorth left as director
Companies in the same industry and area
companydata.dk